A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Pan-Asian Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing Assisted Reproductive Technology Programme
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Jan 2020
Price : $35 *
At a glance
- Drugs Follitropin delta (Primary) ; Follitropin alfa
- Indications Female infertility
- Focus Registrational; Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 12 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 05 Jul 2019 Planned End Date changed from 15 Jul 2020 to 15 Aug 2020.
- 05 Jul 2019 Planned primary completion date changed from 1 Nov 2019 to 1 Feb 2020.